Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Ceci

Showing results (121-130 of 148) with videos related to

Pageof 15
Sort By:
World Journal of Urology|March 16, 2024
Extreme-hypofractionated RT with concomitant boost to the DIL in PCa: a 5-year update on oncological and patient-reported outcomes for the phase II trial "GIVE ME FIVE"Giulia Marvaso, Giulia Corrao, Ilaria Repetti, et al.
Current Opinion in Urology|November 23, 2021
Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: a systematic review of population-based evidenceCharles Laine, Giorgio Gandaglia, Massimo Valerio, et al.
Life (Basel, Switzerland)|July 27, 2024
Image-Guided Stereotactic Body Radiotherapy on Detectable Prostate Bed Recurrence after Prostatectomy in RT-Naïve PatientsRiccardo Santamaria, Mattia Zaffaroni, Maria Giulia Vincini, et al.
The Lancet. Oncology|August 4, 2019
<sup>18</sup>F-fluciclovine PET-CT and <sup>68</sup>Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trialJeremie Calais, Francesco Ceci, Matthias Eiber, et al.
Cancers|January 11, 2022
Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer-Current State and Future PerspectivesAlexander Kretschmer, Roderick C N van den Bergh, Alberto Martini, et al.
Prostate Cancer and Prostatic Diseases|October 26, 2022
Association between age and efficacy of combination systemic therapies in patients with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysisPawel Rajwa, Takafumi Yanagisawa, Isabel Heidegger, et al.
BMC Cancer|December 15, 2023
Multi-omics integrative modelling for stereotactic body radiotherapy in early-stage non-small cell lung cancer: clinical trial protocol of the MONDRIAN studyStefania Volpe, Mattia Zaffaroni, Gaia Piperno, et al.
European Urology Focus|November 28, 2024
Better Oncological Outcomes After Prostate-specific Membrane Antigen Positron Emission Tomography-guided Salvage Radiotherapy Following ProstatectomyConstantinos Zamboglou, Paulina Staus, Martin Wolkewitz, et al.
Surgical Innovation|July 9, 2011
PPH-01 versus PPH-03 to perform STARR for the treatment of hemorrhoids associated with large internal rectal prolapse: a prospective multicenter randomized trialAdolfo Renzi, Antonio Brillantino, Giandomenico Di Sarno, et al.
JAMA Oncology|September 16, 2021
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging TrialThomas A Hope, Matthias Eiber, Wesley R Armstrong, et al.
Pageof 15

Showing results (121-130 of 148) with videos related to

Sort By:
Pageof 15
World Journal of Urology|March 16, 2024
Extreme-hypofractionated RT with concomitant boost to the DIL in PCa: a 5-year update on oncological and patient-reported outcomes for the phase II trial "GIVE ME FIVE"Giulia Marvaso, Giulia Corrao, Ilaria Repetti, et al.
Current Opinion in Urology|November 23, 2021
Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: a systematic review of population-based evidenceCharles Laine, Giorgio Gandaglia, Massimo Valerio, et al.
Life (Basel, Switzerland)|July 27, 2024
Image-Guided Stereotactic Body Radiotherapy on Detectable Prostate Bed Recurrence after Prostatectomy in RT-Naïve PatientsRiccardo Santamaria, Mattia Zaffaroni, Maria Giulia Vincini, et al.
The Lancet. Oncology|August 4, 2019
<sup>18</sup>F-fluciclovine PET-CT and <sup>68</sup>Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trialJeremie Calais, Francesco Ceci, Matthias Eiber, et al.
Cancers|January 11, 2022
Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer-Current State and Future PerspectivesAlexander Kretschmer, Roderick C N van den Bergh, Alberto Martini, et al.
Prostate Cancer and Prostatic Diseases|October 26, 2022
Association between age and efficacy of combination systemic therapies in patients with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysisPawel Rajwa, Takafumi Yanagisawa, Isabel Heidegger, et al.
BMC Cancer|December 15, 2023
Multi-omics integrative modelling for stereotactic body radiotherapy in early-stage non-small cell lung cancer: clinical trial protocol of the MONDRIAN studyStefania Volpe, Mattia Zaffaroni, Gaia Piperno, et al.
European Urology Focus|November 28, 2024
Better Oncological Outcomes After Prostate-specific Membrane Antigen Positron Emission Tomography-guided Salvage Radiotherapy Following ProstatectomyConstantinos Zamboglou, Paulina Staus, Martin Wolkewitz, et al.
Surgical Innovation|July 9, 2011
PPH-01 versus PPH-03 to perform STARR for the treatment of hemorrhoids associated with large internal rectal prolapse: a prospective multicenter randomized trialAdolfo Renzi, Antonio Brillantino, Giandomenico Di Sarno, et al.
JAMA Oncology|September 16, 2021
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging TrialThomas A Hope, Matthias Eiber, Wesley R Armstrong, et al.
Pageof 15